Sarasota Memorial Hospital is among the first wave of U.S. hospitals offering renal denervation, a minimally invasive outpatient procedure to treat people with high blood pressure that does not respond to conventional medications and lifestyle therapies.
“We are very excited to bring this innovative therapy to our community,” said Sarasota Memorial Health Care System Chief Medical Officer James Fiorica, MD. “Uncontrolled hypertension is a leading cause of heart disease, stroke, and kidney failure. For patients who don’t respond to medication, renal denervation offers a crucial new treatment option and a promising new path forward.”
The first device-based treatment for resistant hypertension, renal denervation, was approved by the U.S. Food & Drug Administration in late 2023, but it wasn’t until December 2025 that the Centers for Medicare & Medicaid Services issued a national coverage determination, paving the way for broad insurance coverage and access in 2026…